0001789886-19-000001.txt : 20191217 0001789886-19-000001.hdr.sgml : 20191217 20191217152144 ACCESSION NUMBER: 0001789886-19-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b ITEM INFORMATION: Investment Company Act Section 3(c) ITEM INFORMATION: Section 3(c)(1) FILED AS OF DATE: 20191217 DATE AS OF CHANGE: 20191217 EFFECTIVENESS DATE: 20191217 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Curex Life Science Fund, LP CENTRAL INDEX KEY: 0001789886 IRS NUMBER: 843040522 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-355687 FILM NUMBER: 191289503 BUSINESS ADDRESS: STREET 1: 8200 HWY 100 CITY: NASHVILLE STATE: TN ZIP: 37221 BUSINESS PHONE: 6154981887 MAIL ADDRESS: STREET 1: 8200 HWY 100 CITY: NASHVILLE STATE: TN ZIP: 37221 D 1 primary_doc.xml X0708 D LIVE 0001789886 Curex Life Science Fund, LP 8200 HWY 100 NASHVILLE TN TENNESSEE 37221 6154981887 DELAWARE None None Limited Partnership true 2019 Joshua Trantum 8200 Hwy 100 Nashville TN TENNESSEE 37221 Executive Officer Director Promoter Keith Ferrari 8200 Hwy 100 Nashville TN TENNESSEE 37221 Executive Officer Promoter Pooled Investment Fund Hedge Fund false Decline to Disclose 06b 3C 3C.1 false 2019-12-03 true true true false 0 Indefinite 1500000 Indefinite false 7 0 0 0 false Curex Life Science Fund, LP Joshua R. Trantum Joshua R. Trantum President of general partner 2019-12-17